© 2003 by Oxford University Press
Journal of the National Cancer Institute, Vol. 95, No. 12, 850,
June 18, 2003
© 2003 Oxford University Press
NEWS |
Awards, Appointments, Announcements
Five individuals have been awarded the 2003 International Gairdner Awards, presented by the The Gairdner Foundation of Toronto, Canada. This year’s winners include: Richard Axel, M.D., of Columbia University in New York, Linda B. Buck, Ph.D., of the Fred Hutchinson Cancer Research Center in Seattle, Wayne A. Hendrickson, Ph.D., of Columbia University in New York, Seiji Ogawa, Ph.D., of the Ogawa Laboratories for Brain Function and Research at the Hamano Life Science Research Foundation in Tokyo, and Ralph M. Steinman, M.D., of the Rockefeller University in New York.
The International Gairdner Awards recognize outstanding achievements in medical science. This year’s awards recognize individuals who have made substantial contributions in neuroscience and immunology.
Ronald A. DePinho, M.D., of the Harvard Medical School and the Dana-Farber Cancer Institute in Boston, has been awarded the Peter Steck Memorial Lecture and Juan Fueyo, M.D., of the University of Texas M. D. Anderson Cancer Center in Houston, has been awarded the Peter Steck Memorial Award by the Pediatric Brain Tumor Foundation of the United States. The awards recognize scientists who have made significant contributions to the field of neuro-oncology.
The Roswell Park Cancer Institute in Buffalo, N.Y., has appointed four researchers to its Department of Cancer Genetics.
Andrei V. Bakin, Ph.D., has been appointed an assistant member. Bakin was previously an assistant research professor at the Vanderbilt University School of Medicine in Nashville, Tenn.
Irwin H. Gelman, Ph.D., has been appointed an associate member. He was previously director of virology research and a research associate professor at the Mount Sinai School of Medicine in New York.
Nicoletta Sacchi, Ph.D., has been appointed a distinguished member. She was previously an associate professor of molecular genetics at the University of Milan, Italy, and a visiting professor at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, Md.
Keshav K. Singh, Ph.D., was appointed an associate member. He was previously an assistant professor of oncology and environmental health at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Ellen Vitetta, Ph.D., director of the Cancer Immunobiology Center at the University of Texas Southwestern Medical Center in Dallas, has been elected to the American Academy of Arts and Sciences, a society of the world’s leading scientists, scholars, artists, business people, and public leaders.
Vitetta is internationally recognized for her research on B lymphocytes and interleukin 4 and is a pioneer in the development of immunotoxin therapies for cancer and AIDS.
Mickey Kosloff, Ph.D., a researcher at the Hebrew University of Jerusalem, is the one of this year’s recipients of the Kaye Innovation Awards, presented by the university’s Board of Governors. Kosloff is being recognized for his work on abnormal Ras proteins, which are involved in human cancers. His research is focused on the development of anti-cancer drugs that rescue abnormal Ras proteins.
Liguo Song, Ph.D., has joined the Mass Spectrometry Laboratory at the Biopolymer Resource of the Roswell Park Cancer Institute in Buffalo, N.Y. Song was previously a visiting fellow in the Institute for Biological Sciences at the National Research Council of Canada, Ottawa.
Gabriel Leung has been named executive vice president and president of oncology business for OSI Pharmaceuticals Inc., Melville, N.Y., a biotechnology company that develops products to improve the quality-of-life of cancer patients. Leung was previously a group vice president of global prescription business and head of the global oncology franchise at Pharmacia, Peapack, N.J.
Memorial Sloan-Kettering Cancer Center, North General Hospital, and Polo Ralph Lauren, all in New York, have opened the Ralph Lauren Center for Cancer Care and Prevention in East Harlem, New York. The center will offer prevention, screening, and treatment services to medically underserved populations, and will include a bilingual staff. The center will also conduct research on cultural factors that influence cancer care among medically underserved communities.
Nominations are being accepted for the second annual AACR-Cancer Research and Prevention Foundation Award for Excellence in Cancer Prevention Research. Details about the award and the online nomination process are available from the American Association for Cancer Research at http://www.aacr.org. The deadline for submission is July 1, 2003.
Nominations are being accepted for the new program, Avon Foundation-AACR International Scholars in Breast Cancer Research. More information about the program and a copy of the application form is available from the American Association for Cancer Research at http://www.aacr.org/2003AvonAACR_Scholar_Awards.asp. The deadline to apply is July 1, 2003.
Applications are being accepted for the National Cancer Institute’s Cancer Prevention Fellowship Program. This program offers postdoctoral training opportunities in the field of cancer prevention and control. The deadline to apply is Sept. 1, 2003. For more information, please contact Barbara Redding at 301-496-8640 or br24v{at}nih.gov. Or visit the NCI’s Web site at http://cancer.gov/prevention/pob.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||